/PRNewswire/ - PreveCeutical Medical Inc. (the "Company" or "PreveCeutical") (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H), is proud to announce that Endosane.
PreveCeutical Enters into License Option Agreement with Endosane Pharmaceuticals streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Vancouver, British Columbia (Newsfile Corp. - January 12, 2023) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce that it has
BERLIN and IRVINE, Calif. - Endosane Pharmaceuticals (www.endosane.com), a Berlin-based pharmaceutical company specializing in the systematic exploration and use of the endocannabinoid system for the treatment of neurological, neuropsychiatric, and psychiatric disorders, and the University of California Irvine (UCI)